Clearstone partners to boost biomarkers, esoteric services
Clearstone Central Laboratories is partnering with LabCorp to give clients access to more biomarker and esoteric services.
Clearstone Central Laboratories is partnering with LabCorp to give clients access to more biomarker and esoteric services.
Lonza has licensed the worldwide marketing rights for its tissue-engineering skin substitute technology to Regenicin.
SAFC and Novozymes Biopharma have agreed to extend their partnership by ten years for the exclusive distribution of LONG R3 growth factor, used for industrial cell culture applications.
ClinTec International is to expand in India and Asia Pacific having received investment from Elephant Capital.
Midatech and MonoSol Rx have filed a provisional US patent application covering a nanoparticle film drug delivery system for administering biologics.
Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
Allied Vision Technologies (AVT) says new imaging machine offers “100 per cent inspection” capability to help drugmakers meet quality rules.